Reprise Biomedical is focused on the development and commercialization of biological medical devices that offer advanced solutions for wound healing. In 2019, Reprise took ownership of two products, under a proprietary perfusion decellularization technology license from the University of Minnesota, MiroDerm biologic wound matrix for advanced wound management and MiroFlex biologic matrix for soft tissue reinforcement. Reprise is committed to delivering novel solutions which address unmet surgical needs for advanced wound care. Our transformational, Miro3D wound matrix, is an example of that commitment. Miro3D broadens our wound management portfolio by offering a unique three-dimensional solution for deep and tunnelling wounds.
Cook Medical, founded in 1963, creates innovative medical devices to empower healthcare professionals, helping patients live fully. As healthcare evolves, demand grows for groundbreaking products and better business practices. In an exciting new phase, Cook enhances its unique product portfolio and customer experiences. As a privately held company, Cook embraces the future, guided by values and commitment to clinicians and patients. We expand impact through four pillars: Invention, Connection, People, and Community. Our Vascular and MedSurg divisions collaborate with professionals to address unmet needs, driving innovation to improve lives with a relentless focus on getting patients back to living.
New Horizon Medical Solutions' dedication to patient care sets us apart and drives us to bring high-quality and effective products to healthcare practices across the nation. We are a leading medical device company specializing in biologics and durable medical equipment (DME). Our network includes a diverse range of medical fi elds, such as orthopedic surgery, podiatry, wound care, dermatology, spine, and neurosurgery. Known for our commitment to innovation and excellence, New Horizon Medical Solutions strives to provide top-tier medical products that enhance patient care and improve outcomes
ETS, headquartered in Rolla, Missouri, USA, specializes in developing medical products utilizing proprietary borate-based bioactive glass. Our fl agship product, Mirragen®, represents a breakthrough in wound care technology as the fi rst FDA-cleared inorganic bioactive glass-based solution. Mirragen® is a borate-based bioactive glass fi ber matrix that facilitates quality tissue formation, without the risk of infection that tissue-based products have, all in an easy to use, versatile form factor.
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular-therapy and regenerative-medicine markets. The fatty-acid-rich products from the company’s patented technologies protect the body’s own tissues and enable the body to regenerate tissues. Developed and manufactured in Isafjordur, Iceland, Kerecis medical products are authorized for sale in Europe, the United States. and several other jurisdictions for human-tissue repair. Thousands of patients are treated annually with our technology. And we are broadening our product line to address many more types of soft-tissue damage.
Urgo provides medical devices and products to hospitals, nursing homes and home health agencies – and the patients they treat. Our focused portfolio of products establishes proven protocols for the care and management of wounds, skin, and skin breakdown.
Family-owned since 1912, Juzo manufactures a variety of compression therapy garments designed specifically to offer people affected by venous and lymphatic conditions the freedom to keep moving and maintain an active lifestyle. A global leader, Juzo provides solutions to help improve its customers’ quality of life, not inhibit it. Juzo continuously invests in technology, process improvements, and quality of materials to ensure its products provide comfort, style, ease of use, medical therapy, and value. Advancements, including FiberSoft® technology, trend colors, attractive styles, and fun print designs, promote comfort and fashion without compromising therapeutic compression. Learn more at juzousa.com.
Imbed Biosciences is a privately held medical device company and innovator of SAM™ Antimicrobial Technology, with both commercially available and emerging solutions for the treatment of chronic and acute wounds. Imbed’s revolutionary platform technology enhances skin regeneration by integrating multiple agents into an ultra-thin, biocompatible matrix to facilitate wound healing.
